Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Placebo Spiromax
Teva Pharma GmbH
Asthma
1 trial -
Placebo cannabis oil. Components: cannabis gr... for Refractory Epilepsy
Disc Medicine
Refractory Epilepsy
1 trial -
Placebo capsules for bacterial sexually transmitted…
The George Institute
bacterial sexually transmitted infections
1 trial -
Placebo for AMG 145, EVOLOCUMAB
Amgen
Adults at high risk of cardiovascular events without prior MI or stroke.
1 trial -
Placebo for AMG 334, Erenumab
Amgen
Chronic Migraine
1 trial -
Placebo for AMG 890
Amgen
Cardiovascular Disease
1 trial -
Placebo for Adalimumab
AbbVie
Rheumatoid Arthritis
1 trial -
Placebo for Bepirovirsen Solution for Injection 150 mg/mL
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
Placebo for Bepirovirsen Solution for Injection 150 mg/mL
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
Placebo for Linaclotide
IRONWOOD PHARMACEUTICALS INC
Functional Constipation (FC)
1 trial -
Placebo for MK-7240, tulisokibart
Merck Sharp and Dohme
Hidradenitis Suppurativa
1 trial -
Placebo for Mitapivat, MITAPIVAT
Lacuna Pharma Pty Ltd
Non–Transfusion-Dependent Alpha- or Beta-Thalassemia
1 trial -
Placebo for Nucresiran, ALN-TTRSC04
Alnylam Netherlands B.V.
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)
1 trial -
Placebo for PRAX-628, PRAX-628
Chongqing Precision Biotech Co., Ltd
Focal Epilepsy
1 trial -
Placebo for efgartigimod, ARGX-113
argenx
Chronic Idiopathic thrombocytopenic purpura
1 trial -
Placebo for risankizumab, ABBV-066
AbbVie Deutschland GmbH & Co. KG
Crohn's disease
1 trial -
Placebo in combination with Cytarabine Injection
Moleculin Biotech
Acute Myeloid Leukaemia (AML)
1 trial -
Placebo injections
Centocor B.V.
Rheumatoid Arthritis
1 trial -
Placebo intramuscular injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Spontaneous Uriticaria
1 trial -
Placebo matching AMX0035, AMX0035
Lacuna Pharma Pty Ltd
Progressive Supranuclear Palsy
1 trial -
Placebo matching BI 1291583, BI 1291583
Boehringer Ingelheim
Bronchiectasis
1 trial -
Placebo matching DNTH103, DNTH103
Dianthus Therapeutics, Inc. /DE/
Chronic Inflammatory Demyelinating Polyneuropathy
1 trial -
Placebo matching REGN7508, REGN7508
Lacuna Pharma Pty Ltd
Cancer-Associated Thrombosis (CAT).
1 trial -
Placebo matching to garetosmab, Garetosmab
Lacuna Pharma Pty Ltd
Fibrodysplasia Ossificans Progressiva
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.